HomeComparePOR vs BDX

POR vs BDX: Dividend Comparison 2026

POR yields 3.99% · BDX yields 2.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 POR wins by $42.6K in total portfolio value
10 years
POR
POR
● Live price
3.99%
Share price
$52.62
Annual div
$2.10
5Y div CAGR
30.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$69.5K
Annual income
$15,382.21
Full POR calculator →
BDX
BDX
● Live price
2.27%
Share price
$154.69
Annual div
$3.51
5Y div CAGR
13.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.9K
Annual income
$1,058.14
Full BDX calculator →

Portfolio growth — POR vs BDX

📍 POR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPORBDX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, POR + BDX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
POR pays
BDX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

POR
Annual income on $10K today (after 15% tax)
$339.22/yr
After 10yr DRIP, annual income (after tax)
$13,074.88/yr
BDX
Annual income on $10K today (after 15% tax)
$192.91/yr
After 10yr DRIP, annual income (after tax)
$899.42/yr
At 15% tax rate, POR beats the other by $12,175.46/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of POR + BDX for your $10,000?

POR: 50%BDX: 50%
100% BDX50/50100% POR
Portfolio after 10yr
$48.2K
Annual income
$8,220.17/yr
Blended yield
17.05%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BDX right now

POR
Analyst Ratings
6
Buy
15
Hold
2
Sell
Consensus: Hold
Price Target
$51.14
-2.8% upside vs current
Range: $46.00 — $58.00
Altman Z
1.0
Piotroski
5/9
BDX
Analyst Ratings
16
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$193.80
+25.3% upside vs current
Range: $170.00 — $215.00
Altman Z
2.1
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

POR buys
0
BDX buys
12
PoliticianChamberTickerTypeAmountDate
Ro Khanna🏢 House$BDX▲ Buy$1,001 - $15,0002025-09-29
Lisa McClain🏢 House$BDX▼ Sell$1,001 - $15,0002025-06-24
Lisa McClain🏢 House$BDX▲ Buy$1,001 - $15,0002025-06-17
Rob Bresnahan🏢 House$BDX▲ Buy$1,001 - $15,0002025-05-15
Thomas H. Kean🏢 House$BDX▲ Buy$1,001 - $15,0002025-05-13
Rob Bresnahan🏢 House$BDX▼ Sell$1,001 - $15,0002025-04-08
Jefferson Shreve🏢 House$BDX▼ Sell$15,001 - $50,0002025-03-05
William R. Keating🏢 House$BDX▼ Sell$1,001 - $15,0002024-09-11
Ro Khanna🏢 House$BDX▼ Sell$1,001 - $15,0002024-09-09
John James🏢 House$BDX▼ Sell$1,001 - $15,0002024-09-04
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPORBDX
Forward yield3.99%2.27%
Annual dividend / share$2.10$3.51
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR30.2%13.5%
Portfolio after 10y$69.5K$26.9K
Annual income after 10y$15,382.21$1,058.14
Total dividends collected$43.5K$5.7K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$51.14$193.80

Year-by-year: POR vs BDX ($10,000, DRIP)

YearPOR PortfolioPOR Income/yrBDX PortfolioBDX Income/yrGap
1← crossover$11,220$519.61$10,958$257.59+$262.00POR
2$12,714$709.39$12,024$299.40+$690.00POR
3$14,583$978.20$13,214$348.50+$1.4KPOR
4$16,969$1,365.20$14,545$406.26+$2.4KPOR
5$20,089$1,933.01$16,038$474.35+$4.1KPOR
6$24,280$2,784.72$17,715$554.80+$6.6KPOR
7$30,075$4,095.41$19,606$650.06+$10.5KPOR
8$38,353$6,172.78$21,741$763.12+$16.6KPOR
9$50,617$9,578.59$24,161$897.64+$26.5KPOR
10$69,542$15,382.21$26,910$1,058.14+$42.6KPOR

POR vs BDX: Complete Analysis 2026

PORStock

Portland General Electric Company, an integrated electric utility company, engages in the generation, wholesale purchase, transmission, distribution, and retail sale of electricity in the state of Oregon. It operates six thermal plants, three wind farms, and seven hydroelectric facilities. As of December 31, 2021, the company owned an electric transmission system consisting of 1,274 circuit miles, including 287 circuit miles of 500 kilovolt line, 415 circuit miles of 230 kilovolt line, and 572 miles of 115 kilovolt line. It has 28,206 circuit miles of distribution lines. The company also purchases and sells wholesale natural gas in the United States and Canada. It serves approximately 917 thousand residential, commercial, and industrial customers in 51 cities. The company was founded in 1889 and is headquartered in Portland, Oregon.

Full POR Calculator →

BDXHealthcare

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Full BDX Calculator →
📬

Get this POR vs BDX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

POR vs SCHDPOR vs JEPIPOR vs OPOR vs KOPOR vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.